Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study

Background. Although prolonged-release tacrolimus (PR-T) is widely approved for posttransplantation immunosuppression in kidney recipients, large-scale studies are required to assess long-term outcomes. We present follow-up data from the Advagraf-based Immunosuppression Regimen Examining New Onset D...

Full description

Bibliographic Details
Main Authors: Vincent Pernin, MD, PhD, Maciej Glyda, MD, PhD, Ondrej Viklický, MD, PhD, Aleksander Lõhmus, MD, Lars Wennberg, MD, PhD, Oliver Witzke, MD, Bengt von Zur-Mühlen, MD, PhD, Swapneel Anaokar, MD, Martin Hurst, FRCP(UK), Gbenga Kazeem, PhD, Nasrullah Undre, PhD, Dirk R.J. Kuypers, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2023-03-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001432

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001432

Similar Items